Related Experiment Videos
Aggressive medulloblastoma with high-level N-myc amplification
F H Tomlinson1, R B Jenkins, B W Scheithauer
1Department of Neurologic Surgery, Mayo Clinic Rochester, Minnesota 55905.
Mayo Clinic Proceedings
|April 1, 1994
Summary
This study details a rare aggressive medulloblastoma case with rapid neck metastasis. Genetic analysis revealed N-myc amplification and p53 gene deletion, suggesting a role in the tumor's aggressive behavior.
Area of Science:
- Neuro-oncology
- Cancer Genetics
- Surgical Pathology
Background:
- Medulloblastoma is a primary brain tumor often affecting children.
- Aggressive variants can present with challenging treatment resistance and poor prognoses.
- Dural invasion at initial surgery indicates advanced disease and higher recurrence risk.
Observation:
- A 27-year-old male presented with aggressive cerebellar medulloblastoma with dural invasion.
- Post-surgical resection and radiation, a metastasis occurred along the surgical scar.
- The tumor rapidly invaded the neck, and chemotherapy proved ineffective.
Findings:
- Cytogenetic and molecular studies identified significant chromosomal abnormalities.
- Key genetic alterations included N-myc gene amplification (over 100-fold) and c-myc gene rearrangement.
- A 16-base pair deletion in exon 7 of the p53 tumor suppressor gene was detected.
Implications:
- These genetic findings, particularly N-myc amplification and p53 mutation, may drive medulloblastoma's aggressive phenotype.
- Understanding these molecular drivers is crucial for developing targeted therapies.
- This case highlights the importance of comprehensive genetic profiling in refractory or aggressive brain tumors.